Biological activities of crystalline pertussigen from Bordetella pertussis.
about
Pertussis toxin and adenylate cyclase toxin provide a one-two punch for establishment of Bordetella pertussis infection of the respiratory tractPertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology toolsCloning and sequencing of the pertussis toxin genes: operon structure and gene duplicationPertussis toxin plays an early role in respiratory tract colonization by Bordetella pertussisToward a mechanism-based in vitro safety test for pertussis toxinNovel therapies for the treatment of pertussis diseaseSuppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoproteinPertussis toxin is required for pertussis vaccine encephalopathyInteraction of monoclonal antibodies with pertussis toxin and its subunits.Role of pertussis toxin A subunit in neutrophil migration and vascular permeability.Identification of B-cell epitopes on the S4 subunit of pertussis toxinEnhancement of interleukin-4 production by pertussis toxin.Activation of the vrg6 promoter of Bordetella pertussis by RisAEffect of lymphocytosis-promoting factor from Bordetella pertussis on cerebellar cyclic GMP levelsExtreme cutaneous histamine sensitivity with hay fever and increased IgE concentrations in an unselected population.Endothelial histamine H1 receptor signaling reduces blood-brain barrier permeability and susceptibility to autoimmune encephalomyelitis.Pertussis toxin B-pentamer mediates intercellular transfer of membrane proteins and lipids.Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.Differential expression of alpha 4 integrins on effector memory T helper cells during Bordetella infections. Delayed responses in Bordetella pertussisInduction of polyclonal CD8+ T cell activation and effector function by Pertussis toxin.Analysis of the role of Bphs/Hrh1 in the genetic control of responsiveness to pertussis toxin.Immune response to dimeric subunits of the pertussis toxin B oligomerPertussis toxin analog with reduced enzymatic and biological activities is a protective immunogenEngineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines.Differences in coughing and other responses to intrabronchial infection with Bordetella pertussis among strains of rats.Effects of a diphtheria-tetanus-acellular pertussis vaccine on immune responses in murine local lymph node and lung allergy modelsPertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tractGenetic analysis of the influence of neuroantigen-complete Freund's adjuvant emulsion structures on the sexual dimorphism and susceptibility to experimental allergic encephalomyelitisMolecular cloning of pertussis toxin genes.Contribution of pertussis toxin to the pathogenesis of pertussis diseaseEnhancement of the intensity, persistence, and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice.Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin.Pertussis toxin exacerbates and prolongs airway inflammatory responses during Bordetella pertussis infection.von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitisProperties of pertussis toxin B oligomer assembled in vitro from recombinant polypeptides produced by Escherichia coli.Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule.Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough.Properties of the B oligomer of pertussis toxin
P2860
Q24523604-37F81266-D2A7-4F5F-938D-8A639F189584Q24602050-4C232AB0-5454-4C3C-B5B4-8A5EF05B81D3Q24628759-F780C71D-97F6-4617-BCD2-F14A1A02739CQ24670399-959F8254-FD47-431B-8271-C5AD6BEC49A2Q26861669-8CDC8AC3-0D94-42A8-A123-A5F364E6931DQ28084039-4C7E6734-3A8B-4260-B4C6-B4FF9CA62E76Q30449521-5DD6012F-F5EB-430B-9A0C-66989BEF5446Q30449680-2FD4FE9A-DAFB-470C-BBD5-4E3B13C27122Q30451157-A401FE8B-365B-4149-90F3-688AE4B4356EQ30452850-520CF0C5-FB2E-4ED5-A26D-9EB8B64435D3Q33599636-2F6AE13E-1144-401E-B015-A31207AFD066Q33602262-4F51E0E0-4070-41AD-8F9D-77F6ECAD5551Q33714441-23FF45E2-FD4B-4030-96F4-171C4F5AAB5BQ33912363-509420C1-9778-4748-8E18-6901732C8702Q34071512-3B732E3E-5FB7-4F0D-8CED-40E383637D39Q34279208-202B90E1-056E-40DF-892A-94059A66D16AQ34369927-6FC89772-FD2B-4CE9-83C8-0EA80162D7A3Q34484529-7F068AAE-5500-4DCB-99B7-6781E6C6B7F4Q34541373-9032679D-8801-460F-A9A1-90067CA1ED78Q34706762-876C3624-15AD-43B4-A4AC-29B1175D908AQ34715489-B20535FF-67F9-44FF-8B7F-BEA8B8B40EB4Q35097039-2C46A24A-46B0-4305-81D8-CB4A0F331148Q35106128-20BBB20B-BB43-4F7F-AFF6-225D798865DFQ35107603-D6B8A3EE-4A43-44A2-9BB4-4F5B3DB38358Q35548872-336EBF94-FF5D-4E0D-955C-24C5BA970280Q35558516-55B4C98E-7D31-41DE-B553-DF6FAABF45A8Q35690073-56934AC3-3D58-4B1F-BF46-FD93D617820EQ35783756-E9ED53DB-FBE3-40B8-BC09-3ED1F146ED0CQ35792047-A93C2005-6005-4D1B-BBC1-B9FDE4109933Q36097100-9474FDA7-F088-45D6-B2A1-AE4BEF900E42Q36226458-551862C7-C675-407F-8369-2B6534E18FACQ36347894-DC6D0D77-39F8-4D28-A7F5-9B9463F2C321Q36361184-643AC7C6-109C-4EED-8018-C9D92C2E4DB4Q36396894-3EC669BD-FC51-4CC0-A6C2-CE0C86E1C844Q36853655-F3C7DE03-B021-448C-B360-28AA5B227291Q36945908-01582A1E-50C6-418A-B4FC-4908EE1F5E08Q36956504-07BD9EC5-167F-4B67-A4D4-3EEC43268549Q36975158-D5990883-F5C1-4B34-B8CF-9191336FAA6EQ36980977-1FB1D6A6-E9C3-4DB0-A7E3-A6E2B24E277AQ36990870-242E6143-168F-4BB7-9376-8690A7950F21
P2860
Biological activities of crystalline pertussigen from Bordetella pertussis.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh
1981年學術文章
@zh-hant
name
Biological activities of crystalline pertussigen from Bordetella pertussis.
@ast
Biological activities of crystalline pertussigen from Bordetella pertussis.
@en
type
label
Biological activities of crystalline pertussigen from Bordetella pertussis.
@ast
Biological activities of crystalline pertussigen from Bordetella pertussis.
@en
prefLabel
Biological activities of crystalline pertussigen from Bordetella pertussis.
@ast
Biological activities of crystalline pertussigen from Bordetella pertussis.
@en
P2093
P2860
P1476
Biological activities of crystalline pertussigen from Bordetella pertussis
@en
P2093
P2860
P304
P407
P577
1981-09-01T00:00:00Z